United Therapeutics
UTHR
HK$2,231
Share price
0.06%
Change (1 day)
-9.84%
Change (1 year)
Categories
Market capitalization of United Therapeutics (UTHR)
Market cap: HK$100.65 Billion
As of June 2025 United Therapeutics has a market cap of HK$100.65 Billion. This makes United Therapeutics the world's 1485th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of United Therapeutics from 1999 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | HK$100.65 B | -19.32% |
| 2024 | HK$124.76 B | 54.59% |
| 2023 | HK$80.70 B | -18.5% |
| 2022 | HK$99.02 B | 30.5% |
| 2021 | HK$75.88 B | 45.11% |
| 2020 | HK$52.29 B | 73.71% |
| 2019 | HK$30.10 B | -19.01% |
| 2018 | HK$37.17 B | -25.58% |
| 2017 | HK$49.94 B | 5.88% |
| 2016 | HK$47.17 B | -15.07% |
| 2015 | HK$55.54 B | 17.4% |
| 2014 | HK$47.31 B | 7.09% |
| 2013 | HK$44.18 B | 112.7% |
| 2012 | HK$20.77 B | -2.97% |
| 2011 | HK$21.40 B | -24.4% |
| 2010 | HK$28.31 B | 27.93% |
| 2009 | HK$22.13 B | 97.14% |
| 2008 | HK$11.22 B | -33.72% |
| 2007 | HK$16.93 B | 86.53% |
| 2006 | HK$9.08 B | -27.33% |
| 2005 | HK$12.49 B | 58.8% |
| 2004 | HK$7.86 B | 107.59% |
| 2003 | HK$3.79 B | 39.12% |
| 2002 | HK$2.72 B | 65.98% |
| 2001 | HK$1.64 B | -30.16% |
| 2000 | HK$2.35 B | -58.9% |
| 1999 | HK$5.71 B |
End of Day market cap according to different sources
On Jun 27th, 2025 the market cap of United Therapeutics was reported to be:
HK$100.65 Billion
HK$100.65 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | HK$5.464 T | 5,329.14% | 🇺🇸 USA |
 Gilead Sciences GILD | HK$1.080 T | 973.63% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | HK$154.08 B | 53.09% | 🇮🇱 Israel |
 Pfizer PFE | HK$1.079 T | 972.56% | 🇺🇸 USA |
 Baxter BAX | HK$122.41 B | 21.63% | 🇺🇸 USA |
 Cytokinetics
CYTK | HK$31.08 B | -69.12% | 🇺🇸 USA |
 GlaxoSmithKline GSK | HK$612.80 B | 508.83% | 🇬🇧 UK |
 Cardinal Health CAH | HK$313.21 B | 211.19% | 🇺🇸 USA |